Login
$XERS
$16.49 -$0.21 (1.26%) After hours

Ownership

13F as of Q2 2026 · 180.9M shares outstanding

Who owns XERS?

By type of holder
Institutions 59.6% Insiders 7.3% Everyone else 33.1%
Concentration Top 10 holders own 31.0%
BlackRock, Inc. 8.0% · D. E. Shaw & Co., Inc. 4.3%
Institutional ownership
59.6%
+1.6 pts vs last qtr
Institutional holders
237
+1 vs last qtr
Net shares bought
+2.8M
by institutions in Q2 2026
New / sold out
34 / 33
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • BlackRock, Inc. +1.6M
  • Nuveen, LLC +1.5M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Millennium Management LLC −2.1M
  • Voss Capital, LP SOLD OUT −1.4M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$5.06M
16 notices from 9 people
Shares covered
676.1K
0.37% of the company
Arranged in advance
81%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$860.7K$1.7MDec 2025: $105.2K under a 10b5-1 planDec 2025: $977.0K without a planDecJan 2026: $432.6K under a 10b5-1 planJanFebMar 2026: $466.5K under a 10b5-1 planMarAprMayJun 2026: $393.4K under a 10b5-1 planJunJul 2026: $1.7M under a 10b5-1 planJulAug 2026: $167.8K under a 10b5-1 planAugSep 2026: $637.0K under a 10b5-1 planSepOct 2026: $159.3K under a 10b5-1 planOctNov
Largest proposed sellers
  • Kevin Mcculloch Officer 10b5-1 $2.02M
  • John H Johnson Director $1.07M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025
+118.6%
+21.59% a year
Each share's claim on the business
−54.3%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $75M
over 5 fiscal years
Diluted shares, split-adjusted
76.7M125.6M174.5M2021: 79.0M shares'212022: 135.6M shares'222023: 137.7M shares'232024: 146.8M shares'242025: 172.7M shares'25
Buybacks Stock-based comp
$0$11.2M$22.4M2021 buybacks: $02021 stock comp: $11.4M'212022 buybacks: $02022 stock comp: $12.2M'222023 buybacks: $02023 stock comp: $10.7M'232024 buybacks: $02024 stock comp: $18.4M'242025 buybacks: $02025 stock comp: $22.4M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years59% 1–3 years25% Under 1 year16%
Quarterly turnover
14.0%
of institutional shares changed hands
Top 10 managers, median time held
4.5 years

Super Investors

Investment managers reporting XERS on Form 13F
B
BlackRock, Inc.
Shares
14.5M
% of company
8.03%
Change vs last qtr
+1.6M (+12.2%)
Held since
2021
DE
D. E. Shaw & Co., Inc.
Shares
7.8M
% of company
4.31%
Change vs last qtr
+15.9K (+0.2%)
Held since
2022

28 more super investors behind a free account

See every manager holding Xeris Biopharma Holdings, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting XERS on Form N-PORT; together they hold 22.1% of the company
VT
Position value
$41.1M
% of company
2.87%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$35.3M
% of company
2.46%
% of the fund
0.04%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Xeris Biopharma Holdings, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
EP
Edick Paul R
Insider
Shares
3.8M
% of company
2.12%
Change vs last qtr
—
Held since
—
SJ
Shannon John Patrick Jr
Insider
Shares
2.9M
% of company
1.60%
Change vs last qtr
—
Held since
—

14 more holders behind a free account

See every insider and 5%+ holder of Xeris Biopharma Holdings, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support